David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Denison Mines
DNN
$3.36B
| $679K | ﹤0.01% |
+388,100
| New | +$649K |
|
3227
Kohl's
KSS
$2B
| $677K | ﹤0.01% |
23,601
-808
| -3% | -$18.9K |
|
3228
Ginkgo Bioworks
DNA
$507M
| $677K | ﹤0.01% |
10,009
+9,740
| +3,621% | +$596K |
|
3229
ORIX
IX
$42.9B
| $676K | ﹤0.01% |
36,210
+6,230
| +21% | +$113K |
|
3230
La-Z-Boy
LZB
$1.29B
| $676K | ﹤0.01% |
18,315
+10,797
| +144% | +$348K |
|
3231
Fabrinet
FN
$15.3B
| $675K | ﹤0.01% |
3,545
-79,535
| -96% | -$13.6M |
|
3232
CALL
Tower Semiconductor
TSEM
$24.1B
| $674K | ﹤0.01% |
+22,100
| New | +$576K |
|
3233
News Corp Class B
NWS
$19B
| $674K | ﹤0.01% |
26,193
+6,963
| +36% | +$158K |
|
|
BPMC
3234
PUT
DELISTED
Blueprint Medicines
BPMC
| $673K | ﹤0.01% |
7,300
| – | – |
|
3235
Telkom Indonesia
TLK
$14.9B
| $662K | ﹤0.01% |
+25,682
| New | +$618K |
|
3236
Star Bulk Carriers
SBLK
$3.48B
| $660K | ﹤0.01% |
31,044
-85,852
| -73% | -$1.69M |
|
3237
Euroseas
ESEA
$543M
| $660K | ﹤0.01% |
+26,027
| New | +$587K |
|
3238
McGrath RentCorp
MGRC
$2.79B
| $657K | ﹤0.01% |
+5,494
| New | +$571K |
|
|
GDEN
3239
DELISTED
Golden Entertainment
GDEN
| $657K | ﹤0.01% |
16,445
-12,044
| -42% | -$436K |
|
3240
Adicet Bio
ACET
$83.9M
| $655K | ﹤0.01% |
21,664
+6,359
| +42% | +$139K |
|
3241
Mirum Pharmaceuticals
MIRM
$5.99B
| $655K | ﹤0.01% |
22,178
-1,146
| -5% | -$34.7K |
|
3242
Navigator Holdings
NVGS
$1.37B
| $652K | ﹤0.01% |
+44,782
| New | +$644K |
|
3243
CALL
Sinclair Inc
SBGI
$1.06B
| $652K | ﹤0.01% |
50,000
-10,700
| -18% | -$131K |
|
3244
Erie Indemnity
ERIE
$13.6B
| $649K | ﹤0.01% |
1,937
+1,000
| +107% | +$300K |
|
3245
InMode
INMD
$865M
| $647K | ﹤0.01% |
29,105
-29,362
| -50% | -$659K |
|
|
RNWWW
3246
ReNew Energy Global PLC Warrant
RNWWW
| $645K | ﹤0.01% |
591,955
| – | – |
|
3247
Phibro Animal Health
PAHC
$1.46B
| $644K | ﹤0.01% |
55,625
+12,892
| +30% | +$145K |
|
|
LAZR
3248
DELISTED
Luminar Technologies
LAZR
| $644K | ﹤0.01% |
12,736
+7,802
| +158% | +$388K |
|
|
VRNT
3249
PUT
DELISTED
Verint Systems
VRNT
| $643K | ﹤0.01% |
23,800
+12,300
| +107% | +$285K |
|
3250
Installed Building Products
IBP
$6.55B
| $642K | ﹤0.01% |
3,512
-30,994
| -90% | -$4.35M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.